NDC 71288-712
Cisatracurium Besylate 10 mg per 5 mL injection, solution
On the label: Meitheal Pharmaceuticals Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (API and FDF Site) | Nanjing, China | Makes it | Problems found, fixed voluntarilyNov 10, 2023 · 3 inspections |
Recalls
- Jan 27, 2021 · Class I · Meitheal Pharmaceuticals Inc
Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but confirmed to contain Cisatracurium
Lots: Lot C11507A
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Cisatracurium: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 10 mg per 5 mL
- Approval
- ANDA ANDA211668
- On the market since
- Oct 31, 2019
- Package NDCs
71288-712-9571288-712-96- Official label
- DailyMed (National Library of Medicine), updated Jun 5, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?